RS20210431A1 - Ekstrakti aristotelia chilensis u tretmanu gljivičnih infekcija - Google Patents

Ekstrakti aristotelia chilensis u tretmanu gljivičnih infekcija

Info

Publication number
RS20210431A1
RS20210431A1 RS20210431A RSP20210431A RS20210431A1 RS 20210431 A1 RS20210431 A1 RS 20210431A1 RS 20210431 A RS20210431 A RS 20210431A RS P20210431 A RSP20210431 A RS P20210431A RS 20210431 A1 RS20210431 A1 RS 20210431A1
Authority
RS
Serbia
Prior art keywords
treatment
fungal infections
extracts
aristotelia chilensis
berries
Prior art date
Application number
RS20210431A
Other languages
English (en)
Inventor
Bojan Pavlović
Savić Katarina Jončić
Cem Aydogan
Lidija Šenerović
Lidija Đokić
Ivana Morić
Aleksandar Pavić
Nada Stanković
Original Assignee
Phytonet Doo
Inst Za Molekularnu Genetiku I Geneticko Inzenjerstvo Univerziteta U Beogradu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phytonet Doo, Inst Za Molekularnu Genetiku I Geneticko Inzenjerstvo Univerziteta U Beogradu filed Critical Phytonet Doo
Priority to RS20210431A priority Critical patent/RS20210431A1/sr
Priority to CA3215039A priority patent/CA3215039A1/en
Priority to PCT/RS2022/000005 priority patent/WO2022216171A1/en
Priority to BR112023020727A priority patent/BR112023020727A2/pt
Priority to CN202280026927.5A priority patent/CN117120066A/zh
Priority to EP22726321.7A priority patent/EP4319783A1/en
Priority to JP2023562482A priority patent/JP2024516129A/ja
Priority to US18/286,095 priority patent/US20240197800A1/en
Priority to KR1020237038416A priority patent/KR20240035742A/ko
Publication of RS20210431A1 publication Critical patent/RS20210431A1/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Ovaj pronalazak obezbeđuje profilaktičko i terapeutsko prirodno i bezbedno sredstvo, koje sadrži ekstrakt bobica Aristotelia chilensis kao aktivnu supstancu ili ekstrakte nekog drugog bobičastog voća, za prevenciju i lečenje gljivičnih infekcija kandidijaza u digestivnom, urogenitalnom traktu ali i kod sistemskih oboljenja, izazvanih gljivicama, posebno iz roda Candida naročito Candida albicans, mehanizmom inhibicije filamentacije. Ostale bobice mogu biti iz grupe aronije, brusnice, borovnice, ribizle ili drugog jagodičastog voća.
RS20210431A 2021-04-07 2021-04-07 Ekstrakti aristotelia chilensis u tretmanu gljivičnih infekcija RS20210431A1 (sr)

Priority Applications (9)

Application Number Priority Date Filing Date Title
RS20210431A RS20210431A1 (sr) 2021-04-07 2021-04-07 Ekstrakti aristotelia chilensis u tretmanu gljivičnih infekcija
CA3215039A CA3215039A1 (en) 2021-04-07 2022-04-06 Aristotelia chilensis extracts for treating fungal infections
PCT/RS2022/000005 WO2022216171A1 (en) 2021-04-07 2022-04-06 Aristotelia chilensis extracts for treating fungal infections
BR112023020727A BR112023020727A2 (pt) 2021-04-07 2022-04-06 Extratos de aristotelia chilensis para o tratamento de infecções fúngicas
CN202280026927.5A CN117120066A (zh) 2021-04-07 2022-04-06 一种用于治疗真菌感染的阿里斯托特利亚智利植物提取物
EP22726321.7A EP4319783A1 (en) 2021-04-07 2022-04-06 Aristotelia chilensis extracts for treating fungal infections
JP2023562482A JP2024516129A (ja) 2021-04-07 2022-04-06 真菌感染症治療用アリストテリア・チレンシス抽出物
US18/286,095 US20240197800A1 (en) 2021-04-07 2022-04-06 Aristotelia chilensis EXTRACTS FOR TREATING FUNGAL INFECTIONS
KR1020237038416A KR20240035742A (ko) 2021-04-07 2022-04-06 곰팡이 감염 치료를 위한 아리스토텔레스 칠렌시스 추출물

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RS20210431A RS20210431A1 (sr) 2021-04-07 2021-04-07 Ekstrakti aristotelia chilensis u tretmanu gljivičnih infekcija

Publications (1)

Publication Number Publication Date
RS20210431A1 true RS20210431A1 (sr) 2022-10-31

Family

ID=81851332

Family Applications (1)

Application Number Title Priority Date Filing Date
RS20210431A RS20210431A1 (sr) 2021-04-07 2021-04-07 Ekstrakti aristotelia chilensis u tretmanu gljivičnih infekcija

Country Status (9)

Country Link
US (1) US20240197800A1 (sr)
EP (1) EP4319783A1 (sr)
JP (1) JP2024516129A (sr)
KR (1) KR20240035742A (sr)
CN (1) CN117120066A (sr)
BR (1) BR112023020727A2 (sr)
CA (1) CA3215039A1 (sr)
RS (1) RS20210431A1 (sr)
WO (1) WO2022216171A1 (sr)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1344516A1 (de) 2002-03-12 2003-09-17 Cognis Iberia, S.L. Antioxidative Zubereitungen
US20070065396A1 (en) 2005-09-21 2007-03-22 Tracie Martyn International, Llc Topical macqui berry formulation
EP2344154B1 (en) 2009-10-21 2016-12-07 Maqui New Life S.A. Compositions that include anthocyanidins and methods of use
FI20105710A0 (fi) * 2010-06-18 2010-06-18 Pirjo Paernaenen Valmiste suun mikrobiflooran tasapainottamiseksi
JP5968610B2 (ja) 2011-10-24 2016-08-10 株式会社ファイン マクイベリー含有抗酸化組成物
FR3027228B1 (fr) 2014-10-20 2016-12-09 Valbiotis Composition comprenant un melange d'extraits vegetaux et utilisation pour agir sur le metabolisme glucidique et/ou lipidique
TW201709920A (zh) 2015-09-08 2017-03-16 大江生醫股份有限公司 具抗氧化功能之智利酒果多莓果組合物
CL2015003798A1 (es) 2015-12-31 2016-06-17 Univ Santiago Chile Composición natural antioxidante y antibacteriana, elaborada a partir de extractos fenolicos de aristotelia chilensis y procesos de obtención.

Also Published As

Publication number Publication date
CN117120066A (zh) 2023-11-24
KR20240035742A (ko) 2024-03-18
WO2022216171A1 (en) 2022-10-13
US20240197800A1 (en) 2024-06-20
BR112023020727A2 (pt) 2024-02-06
EP4319783A1 (en) 2024-02-14
JP2024516129A (ja) 2024-04-12
CA3215039A1 (en) 2022-10-13

Similar Documents

Publication Publication Date Title
Rane et al. Cranberry-derived proanthocyanidins prevent formation of Candida albicans biofilms in artificial urine through biofilm-and adherence-specific mechanisms
Wright et al. The prevention of fish spoilage by high antioxidant Australian culinary plants: Shewanella putrefaciens growth inhibition
Bassiri-Jahromi et al. In vivo comparative evaluation of the pomegranate (Punica granatum) peel extract as an alternative agent to nystatin against oral candidiasis
WO2019004757A3 (ko) 줄기세포 유래의 엑소좀을 유효성분으로 포함하는 조성물의 가려움증 억제 또는 개선 용도
WO2019209227A3 (en) Solid oral formulations comprising herbal extracts
Celık et al. In vitro antimicrobial and antioxidant properties of Ganoderma lucidum extracts grown in Turkey.
Jampílek et al. Impact of nanoparticles on toxigenic fungi
De Brucker et al. Potentiation of antibiofilm activity of amphotericin B by superoxide dismutase inhibition
RS20210431A1 (sr) Ekstrakti aristotelia chilensis u tretmanu gljivičnih infekcija
Yadav et al. Present scenarios and future prospects of herbal nanomedicine for antifungal therapy
Han et al. In vitro anti-Malassezia activity of Castanea crenata shell and oil-soluble Glycyrrhiza extracts
TR2023012497T2 (tr) Mantar enfeksi?yonlarinin tedavi?si? i?çi?n aristotelia chilensis ekstreleri?
EP4218782A4 (en) COMPOSITION FOR THE PREVENTION AND TREATMENT OF BENIGN PROSTATE HYPERPLASIA WITH FRUIT EXTRACTS OF ELAEAGNUS MULTRFLORA THUNB. ACTIVE INGREDIENT AS ACTIVE INGREDIENT
Padhi et al. Silver-based nanostructures as antifungal agents: Mechanisms and applications
WO2011112002A3 (ko) 들쭉 추출물 또는 들쭉 분획물을 유효 성분으로 함유하는 황반 변성증의 치료, 예방 또는 개선용 조성물
Lee et al. Antimutagenic and antioxidative effects of polysaccharides isolated from the water extract of Ganoderma lucidum
KR20170094900A (ko) 산딸기 잎 추출물을 함유한 항아토피 효능을 갖는 피부 개선용 화장료 조성물
Quadir Ethnomycology of mushrooms and their antioxidant properties
WO2020180139A3 (ko) 색소가 제거된 치자 추출물을 유효성분으로 포함하는 아토피 피부염의 예방, 개선 또는 치료용 조성물
Naseema et al. Chemotherapeutic effect of piperine solid lipid nanoparticles against benzo (a) pyrene: Induced lung cancer in mice
Tayel et al. Application of edible nanocomposites from chitosan/fenugreek seed mucilage/selenium nanoparticles for protecting lemon from green mold
WO2020021509A3 (en) Composition containing beclomethasone for the prevention and the treatment of bacterial prostatitis and vaginitis
Mufeed et al. Role of antioxidants in dentistry
Han Synergistic antifungal activity against disseminated candidiasis by combination therapy of crataegi fructus extract and fluconazole
Savu et al. ANTI-CANDIDA ACTIVITY OF FLAVONOIDS-AN OVERVIEW.